Correlated Drug Terms (3)

---

	Name (Synonyms)	Correlation
drug2942	pathogen reduced SARS-CoV-2 convalescent plasma Wiki	1.00
drug2136	SARS-CoV-2 diagnostic rapid test Wiki	0.71
drug1822	Placebo Wiki	0.06

Correlated MeSH Terms (1)

---

	Name (Synonyms)	Correlation
D018352	Coronavirus Infections NIH	0.04

Correlated HPO Terms (0)

---

	Name (Synonyms)	Correlation

Primary Outcomes

Description: The primary outcome is the determination of the concentration of anti-SARS-CoV-2 antibodies IgG, IgM, and IgA classes in relation to the categories of cured patients according to the time from the date of cure from the COVID-19 disease to the date of examination.

Measure: Determination of the concentration of anti-SARS-CoV-2 antibodies in relation to the categories of cured patients.

Time: May 2020

---

Secondary Outcomes

Description: The determination of the concentration of anti-SARS-CoV-2 antibodies IgG, IgM, and IgA classes in relation to the categories of cured patients according to their age: category 8-17, 18-39, 40-59, 60 and more years and according to the severity of the disease.

Measure: Determination of the concentration of anti-SARS-CoV-2 antibodies in relation to the age and to the severity of the disease.

Time: June 2020

---

Description: The quantification of the dependence of the change in the concentration of anti-SARS-CoV-2 antibodies IgG, IgM, and IgA classes on the time since cure (analysis by statistical model)

Measure: The quantification of the dependence of the change in the concentration of anti-SARS-CoV-2 antibodies.

Time: June 2020

---

Other Outcomes

Description: The identification of individuals in the study population, who can be contacted as voluntary donors of convalescent plasma, which is one of the therapeutic modalities in patients with severe COVID-19 disease.

Measure: The identification of potential donors of convalescent plasma.

Time: June2020

---